PODOCYTE CELL LINEAGE IN GENITOURINARY DEVELOPMENT
泌尿生殖发育中的足细胞细胞谱系
基本信息
- 批准号:6310782
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
The long-term goals of the applicant's research program will test the following
two hypotheses: 1) that the podocyte (glomerular visceral epithelial cell) is
required for glomerular angiogenesis during development and 2) that the
podocyte is pivotal in progression of chronic renal dysfunction due to a
variety of underlying causes that include diabetes, aging and inflammation. The
promoter of a podocyte-specific gene, nephrin, has been cloned. A transgene
containing 1.25-kb of the 5' flanking region of the human nephrin gene
recapitulates the endogenous expression of the nephrin mRNA transcript, and is
only expressed in podocytes in capillary-loop and mature stage glomeruli of the
developing murine kidney. The proposed studies will use this promoter to
generate novel reagents to delineate the role of the podocyte in kidney
development and disease. The main objective of the present application is to
develop mouse model systems to manipulate podocyte gene expression in vitro and
in vivo. The Specific Aims include: 1. To generate a podocyte-specific
Cre-recombinase mouse line in order to delete and over-express genes in a
cell-specific manner during renal development. 2. To generate mouse founder
lines that can be used to modify gene activity in an inducible manner in
podocytes. 3. To isolate novel murine podocyte cell lines that expresses a
"living" marker of differentiation. 4. To further characterize the cis-acting
elements within the 1.25-kb podocyte-specific promoter of the nephrin gene in
order to identify trans-acting factors that are responsible for
podocyte-specific expression. 5. To generate a podocyte-specific knockout of
vascular endothelial growth factor (VEGF).
The reagents generated in the present application will allow both temporal and
spatial modification of gene activity specifically in podocytes. It will be
possible to manipulate candidate genes involved in glomerular angiogenesis and
to determine the role of the podocyte in setting up the glomerular filtration
barrier. In future studies, these reagents will be useful to determine the role
of the podocyte in glomerulosclerosis and ultimately, to identify therapeutic
targets for chronic renal disease.
描述(改编自应用程序)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN E. QUAGGIN其他文献
SUSAN E. QUAGGIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN E. QUAGGIN', 18)}}的其他基金
NUKIDs: Scientist Training Program in Kidney Disease
NUKID:肾脏疾病科学家培训计划
- 批准号:
9252459 - 财政年份:2016
- 资助金额:
$ 10万 - 项目类别:
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma
激活血管生成素-Tie2 通路治疗高眼压和青光眼
- 批准号:
9106642 - 财政年份:2016
- 资助金额:
$ 10万 - 项目类别:
Exploiting Tie2 Activation for the Treatment of Vascular Diseases
利用 Tie2 激活治疗血管疾病
- 批准号:
8767584 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Exploiting Tie2 Activation for the Treatment of Vascular Diseases
利用 Tie2 激活治疗血管疾病
- 批准号:
9276763 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Exploiting Tie2 Activation for the Treatment of Vascular Diseases
利用 Tie2 激活治疗血管疾病
- 批准号:
8898211 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Collaborative R&D
膵癌腫瘍内線維化に着目した術前化学療法効果予測に関する画像biomarkerの確立
建立预测胰腺癌瘤内纤维化术前化疗效果的影像生物标志物
- 批准号:
24K18824 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
- 批准号:
10073169 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Collaborative R&D